Acute effects of topical forskolin on aqueous humor dynamics in man
- PMID: 3784136
Acute effects of topical forskolin on aqueous humor dynamics in man
Abstract
Previous reports concerning the acute effects of topical forskolin on the intraocular pressure (IOP) and the aqueous humor dynamics in human eyes gave conflicting results, and this led us to reevaluate the effects of this drug in a total of 20 young normal Japanese volunteers. Fifty microliter of 1% forskolin was instilled in one eye, and the vehicle to the fellow control eye. After two instillations of the drug at an interval of 5 minutes, the maximum IOP fall of 2.4 +/- 1.3 mmHg occurred after 1 hour; a single instillation had no significant effect. The effects on the aqueous flow rate and iris permeability factor were determined by the oral fluorescein method. Two instillations of the drug reduced the aqueous flow rate to 87 +/- 7% of the control, while the iris permeability factor was increased to 114 +/- 11% (mean +/- SD, N = 10, P less than 0.005). Pretreatment with topical 0.25% 1-timolol in both eyes 1 hour prior to the drug administration did not significantly alter the forskolin effects.
Similar articles
-
Acute effects of topical phenylephrine on aqueous humor dynamics and corneal endothelial permeability in man.Jpn J Ophthalmol. 1983;27(2):340-5. Jpn J Ophthalmol. 1983. PMID: 6620717 Clinical Trial.
-
The ocular penetration of topical forskolin and its effects on intraocular pressure, aqueous flow rate and cyclic AMP level in the rabbit eye.Jpn J Ophthalmol. 1990;34(4):428-35. Jpn J Ophthalmol. 1990. PMID: 1964483
-
Effect of topically applied forskolin on aqueous humor dynamics in cynomolgus monkey.Invest Ophthalmol Vis Sci. 1984 Oct;25(10):1206-9. Invest Ophthalmol Vis Sci. 1984. PMID: 6541215
-
Studies of aqueous humor dynamics in man. IV. Effects of pilocarpine upon measurements in young normal volunteers.Invest Ophthalmol. 1975 Nov;14(11):848-53. Invest Ophthalmol. 1975. PMID: 1184317
-
Effect of MK-507 on aqueous humor dynamics in normal human eyes.Jpn J Ophthalmol. 1994;38(1):92-6. Jpn J Ophthalmol. 1994. PMID: 7933704
Cited by
-
Dual-drug delivery system based on in situ gel-forming nanosuspension of forskolin to enhance antiglaucoma efficacy.AAPS PharmSciTech. 2010 Mar;11(1):322-35. doi: 10.1208/s12249-010-9388-x. Epub 2010 Feb 25. AAPS PharmSciTech. 2010. PMID: 20182824 Free PMC article.
-
Herbal and Natural Treatments for the Management of the Glaucoma: An Update.Biomed Res Int. 2023 Nov 17;2023:3105251. doi: 10.1155/2023/3105251. eCollection 2023. Biomed Res Int. 2023. PMID: 38027044 Free PMC article. Review.
-
Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury.Mol Vis. 2015 Jun 29;21:718-29. eCollection 2015. Mol Vis. 2015. PMID: 26167113 Free PMC article.
-
Rational Basis for Nutraceuticals in the Treatment of Glaucoma.Curr Neuropharmacol. 2018;16(7):1004-1017. doi: 10.2174/1570159X15666171109124520. Curr Neuropharmacol. 2018. PMID: 29119928 Free PMC article. Review.
-
Efficacy and safety of 1% forskolin eye drops in open angle glaucoma - An open label study.Saudi J Ophthalmol. 2015 Jul-Sep;29(3):197-200. doi: 10.1016/j.sjopt.2015.02.003. Epub 2015 Mar 5. Saudi J Ophthalmol. 2015. PMID: 26155078 Free PMC article.